0007-4201 : Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 0007-4201
Labeler: Glaxosmithkline LLC
Product Type: Human Prescription Drug
Drug Name:  Hycamtin
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: NDA020671
Rev. Date: 


NDC Package Codes:

  • 0007-4201-01: 1 VIAL IN 1 PACKAGE (0007‑4201‑01) > 4 ML IN 1 VIAL

Active Ingredients:

  • Topotecan Hydrochloride

Dosage Strength:

  • 4 mg/4mL

Pharmaceutical Classes:

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0007-4205 Hycamtin 0.25 mg Oral Capsule by Glaxosmithkline LLC
  • 0007-4207 Hycamtin 1 mg Oral Capsule by Glaxosmithkline LLC
  • 0078-0672 Hycamtin .25 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0673 Hycamtin 1 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0674 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation
  • 12064-000 Hycamtin .25 mg Oral Capsule by Glaxosmithkline Manufacturing Spa
  • 12064-001 Hycamtin 1 mg Oral Capsule by Glaxosmithkline Manufacturing Spa
  • 12064-002 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa
  • 66758-101 Hycamtin .25 mg Oral Capsule by Sandoz Inc
  • 66758-102 Hycamtin 1 mg Oral Capsule by Sandoz Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0007-4201 QR Code

< Prev: 0007-4142Next: 0007-4205 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.